Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹903 Cr₹1,290 Cr₹582 Cr₹484 Cr₹811 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹903 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹903 Cr
Mar2025₹1,290 Cr
Mar2024₹582 Cr
Mar2023₹484 Cr
Mar2022₹811 Cr

How is Cash Flow from Operating Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹903 Cr
-29.97
Mar2025 ₹1,290 Cr
121.63
Mar2024 ₹582 Cr
20.20
Mar2023 ₹484 Cr
-40.27
Mar2022 ₹811 Cr -

Compare Cash Flow from Operating Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,921.8 Cr -1.3% 0.2% -6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.3%

0.2%

-6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses